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Abstract
Lipoic acid (LA) is a dithiol-containing cofactor that is essential for the function of a-keto acid dehydrogenase complexes. LA
acts as a reversible acyl group acceptor and ‘swinging arm’ during acyl-coenzyme A formation. The cofactor is post-
translationally attached to the acyl-transferase subunits of the multienzyme complexes through the action of octanoyl
(lipoyl): N-octanoyl (lipoyl) transferase (LipB) or lipoic acid protein ligases (LplA). Remarkably, apicomplexan parasites
possess LA biosynthesis as well as scavenging pathways and the two pathways are distributed between mitochondrion and
a vestigial organelle, the apicoplast. The apicoplast-specific LipB is dispensable for parasite growth due to functional
redundancy of the parasite’s lipoic acid/octanoic acid ligases/transferases. In this study, we show that LplA1 plays a pivotal
role during the development of the erythrocytic stages of the malaria parasite. Gene disruptions in the human malaria
parasite P. falciparum consistently were unsuccessful while in the rodent malaria model parasite P. berghei the LplA1 gene
locus was targeted by knock-in and knockout constructs. However, the LplA1(2) mutant could not be cloned suggesting a
critical role of LplA1 for asexual parasite growth in vitro and in vivo. These experimental genetics data suggest that
lipoylation during expansion in red blood cells largely occurs through salvage from the host erythrocytes and subsequent
ligation of LA to the target proteins of the malaria parasite.
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Introduction
Lipoic acid (6,8-thioctic acid, LA) is an essential cofactor for the
multienzyme complexes pyruvate dehydrogenase (PDH), a-
ketoglutarate dehydrogenase (KGDH), branched chain a-keto
acid dehydrogenase (BCDH) and the glycine cleavage system
(GCS). These enzyme complexes are composed of three or four
subunits which themselves are oligomers [1,2]. The three subunits
that comprise the a-keto acid dehydrogenase complexes (KADH)
are the a-keto acid decarboxylase (or E1), the acyltransferase (or
E2), which uses lipoamide as a cofactor, and the dihydrolipoamide
dehydrogenase (or E3). LA is post-translationally attached to E2
and functions as the so-called ‘‘swinging arm’’ in the reaction
catalysed by KADH complexes, accepting the acyl-moiety from
E1 and transferring it to coenzyme A to form acyl-CoA [1].
During this reaction the lipoamide cofactor is reduced and
subsequently re-oxidised by E3 to regenerate its ability to accept
the next acyl-moiety from E1. The GCS works in a similar way to
the KADH, with the H-protein being the lipoylated heart of this
complex [3].
Usually these enzyme complexes are found in the mitochon-
drion of eukaryotic cells, but plastid-bearing organisms also possess
a PDH in the plastid that provides substrates for type II fatty acid
biosynthesis operating in the organelle [4]. This situation requires
lipoylation machineries in both the mitochondrion and plastids
[5].
In most microorganisms, lipoylation occurs through salvage and
subsequent ligation of LA to the target protein employing lipoic
acid protein ligases (LplA) [6]. LplA attach scavenged LA to the
substrate protein in an ATP-dependent reaction. The first step of
the reaction leads to the formation of a LA-AMP intermediate and
the release of pyrophosphate. The activated lipoyl-moiety is then
attached to the e-amino group of a specific lysine residue in the
lipoyl-domain of the E2-subunit or the H-protein while AMP is
released [6]. In the absence of exogenous LA, bacteria synthesise
LA de novo. They ligate the octanoyl-moiety of octanoyl-acyl carrier
protein (ACP), an intermediate of fatty acid biosynthesis, to the
E2-apo-proteins or apo-H-protein using octanoyl (lipoyl) : N-
octanoyl (lipoyl) transferase (LipB). Subsequently, lipoic acid
synthase (LipA) catalyses the insertion of two sulphurs into
position C6 and C8 of the octanoyl-moiety to form the lipoyl-
arm required for KADH and GCS activities [6].
In the apicomplexan parasites Plasmodium falciparum, the
causative agent of human malaria, and Toxoplasma gondii, causing
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toxoplasmosis, LA metabolism has some peculiar features that
might be exploitable for future drug development. The parasites
possess a single mitochondrion and a single remnant plastid called
apicoplast, and both organelles contain enzyme complexes that
require lipoylation [7–9]. Consistent with this is that both
organelles possess lipoylation machineries [8,10–12]. In contrast
to other plastid-containing eukaryotes, the apicomplexan mito-
chondrion exclusively uses salvaged LA while the plastid cannot
salvage LA from its environment but relies solely on de novo
biosynthesis of the cofactor [13–15]. Interestingly, Plasmodium
possesses two functional LplA-like proteins with LplA1 being
present in the mitochondrion and LplA2 showing dual localisation
to the mitochondrion and apicoplast [11,16]. This suggests
potential redundancy between the lipoylation pathways and
indeed knockout of the apicoplast targeted LipB gene was not
lethal for P. falciparum intraerythrocytic stages suggesting that the
dually targeted LplA2 compensates for the loss of LipB function
[16]. Down-regulation of acyl carrier protein (ACP) expression in
T. gondii revealed that lipoylation levels of the apicoplast PDH was
ablated suggesting that de novo fatty acid biosynthesis operating in
the organelle is the major source for the LA precursor octanoyl-
ACP [15]. This is similar to a study by Witkowski and colleagues
[17] who found that one of the major products of mitochondrial
fatty acid biosynthesis in mammalian cells is octanoyl-ACP, which
is efficiently ligated to the mitochondrial H-protein. Similarly, it
was reported that one of the main roles for mitochondrial fatty
acid biosynthesis in plants and the protozoan parasite Trypanosoma
brucei is the generation of octanoyl-ACP to serve as substrate for
LA biosynthesis [18,19]. In the light of these studies, it appears
imperative to obtain further insights into the importance of the
mitochondrial LA salvage pathways present in Plasmodium which
clearly is essential to provide LA to the KADH and GCS with the
absence of LA biosynthesis in the mitochondrion. This study
aimed to elucidate the role of LplA1 in both P. falciparum and P.
berghei using reverse genetics approaches.
Results
Knockout studies of LplA1 in P. falciparum
In order to obtain insights into the importance of LA salvage by
LplA1 we decided to attempt to knockout the LplA1 gene in P.
falciparum. We first targeted the P. falciparum LplA1 gene by single
cross-over recombination using the construct pHH1-LplA1-KO.
The KO-construct lacks the ATG start codon and is truncated at
the 39 end so that upon recombination of the plasmid by single
cross-over two non-functional gene copies are generated. The first
copy retains the endogenous promoter and the start codon but is
truncated at the 39end through the integration of a premature stop
codon into the construct and the second copy is without promoter
and start codon (Fig. 1A). Two independently transfected parasite
lines were generated and each was taken through three drug
selection cycles in order to select for parasites where the PfLplA1
locus had been disrupted by the transfection plasmid. Genomic
DNA was isolated and analysed by diagnostic Southern blotting
(Fig. 1B). This revealed the presence of endogenous PfLplA1
(1.9 kb band) and linearised plasmid (6 kb band), but no
integration events into the parasite genome were detected (Fig. 1B).
In order to analyse whether this lack of recombination was due
to the essential role of PfLplA1 for parasite survival or whether
other reasons prevent targeting of the PfLplA1 gene locus, two
approaches were taken. First, parasites were transfected with the
knock-in construct pHH1-LplA1-KOkon, which retains the entire
39end. Upon single cross-over recombination the recombinant
locus is predicted to contain one functional gene copy whereas the
second copy lacks the ATG start codon and should, therefore, be
non-functional (Fig. 2A). Similar as described above, parasites
were taken through three drug selection cycles after transfection
and their genotypes were analysed by Southern blotting (Fig. 2B).
Probing the blot with the PfLplA1 open reading frame (ORF)
revealed that after transfection the parasites contained the plasmid
(6 kb band) and the endogenous PfLplA1 gene (1.9 kb band).
During drug selection an additional band of ,9 kb appeared
which was also detected by the hDHFR probe (Fig. 2B, right
panel). This suggests that the pHH1-LplA1-KOkon plasmid
carrying the selectable marker had targeted a gene locus other
than PfLplA1 since the 9 kb band in the Southern blot did not
correspond to the expected diagnostic restriction pattern after
recombination with the PfLplA1 gene locus. It is unknown which
gene locus was targeted by the transfection plasmid but some of
the regulatory elements present in pHH1-LplA1-KOkon poten-
tially might lead to recombination with the parasite genome. The
suggestion of a stable integration of pHH1-LplA1-KOkon into an
unrelated gene locus is not only consistent with the appearance of
the prominent ,9 kb band that cross-reacted with both the
PfLplA1 probe and the hDHFR probe but also the concomitant loss
of the episome from the parasites despite drug selection.
Presumably this stable integration into the parasite genome makes
particularly difficult to select for a gene knockout especially if
disruption of the gene would result in a growth defect of the null
mutants. Similarly, the knock-in of a control plasmid could
possibly result in a growth phenotype given that the gene locus is
altered by the integration of the transfection plasmid. Confirma-
tion that an unrelated gene locus was targeted by pHH1-LplA1-
KOkon came from pulsed field gel electrophoresis (PFGE), where
the PfLplA1 probe detected a signal on chromosome 13, which is
presumably the endogenous PfLplA1 gene in wild-type parasites. In
contrast, in the LplA1-KOkon parasites the probe detected an
additional signal that is likely to correspond to the transfection
plasmid integrated into an unrelated gene locus present on one of
the smaller chromosomes (Fig. 2C; left panel,,Chr.10). The same
signal was detected with the hDHFR probe corroborating the
conclusion that the transfected control plasmid readily targeted a
gene locus other than PfLplA1 (Fig. 2C, right panel).
As a second approach, parasites that already contained the
pHH1-LplA1-KO plasmid were transfected with an additional
plasmid carrying an expression cassette of P. berghei LplA1 ORF. It
is likely that the P. berghei protein can replace the P. falciparum
LplA1 function given the high degree of amino acid similarity
(,70%) of the two proteins (Fig. 3). Expression of the related P.
berghei LplA1 in pHrBI-PbLplA1 is controlled by the P. falciparum
Hsp86 promoter resulting in expression of P. berghei LplA1
throughout blood stage development [20]. This approach was
taken to allow a knockout of the P. falciparum gene through pHH1-
LplA1-KO and concomitantly express a copy of PbLplA1 from an
episome, which should not recombine with the endogenous gene
locus. Parasites already bearing the pHH1-LplA1-KO episomally
were co-transfected with pHrBI-PbLplA1 (Fig. 4A) and the
genotype of the obtained transfectants was analysed (Fig. 4). After
transfection (in cycle 0) the endogenous gene was present and in
addition two bands of 6 kb and 9 kb, respectively were detected in
the blot using the PfLplA1 probe (Fig. 4 B, lane 2). The 6 kb
fragment corresponds to pHH1-LlpA1-KO while it is not clear
what the 9 kb fragment represents. The possibility that this
fragment is due to cross-reactivity between the PfLplA1 probe and
the pHrBI-PbLplA1 plasmid was ruled out. In a control
experiment, where wild-type P. falciparum had been transfected
with pHrBI-PbLplA1, the plasmid was only detected with the BSD-
specific probe and not the PfLplA1 probe (Fig. 5A,B). In the
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following selection cycles, the 6 kb band diagnostic for the KO-
plasmid disappeared and the only band in addition to the PfLplA1
wild-type signal that reacted with both the PfLplA1 and the hDHFR
probes was a ,9 kb fragment (Fig. 4B,C). This suggests that
pHH1-LpA1-KO had recombined with a gene locus other than
PfLplA1 despite the presence of the episome bearing the P. berghei
LplA1 gene. To further analyse the genotype of the double
transfected parasites, PFGE was performed and the blot was
probed with the PfLplA1-probe, the hDHFR-probe and the BSD-
probe. This experiment revealed that the PfLplA1 gene was
undisrupted on chromosome 13 and that the two plasmids
appeared to be present on a chromosome smaller than
chromosome 10, which was not resolved at the bottom of the
PFGE gel (Fig. 4D). Further, it should be noted that the PfLplA1
probe also detected the presence of a LplA1 gene copy on the
smaller chromosome suggesting that at least pHH1-LplA1-KO still
carried the LplA1-KO cassette. This suggests that the BSD-positive
signal on the smaller chromosome also corresponds to the entire
pHrBI-PbLplA1 plasmid. It cannot be excluded that pHH1-LplA1-
KO and pHrBI-PbLplA1 had actually recombined with each other
before they recombined with the non-related gene locus. This
possibility was not further analysed. In order to analyse whether
the PbLplA1 copy that was introduced into the parasites was
actually expressed and thus potentially would compensate for
PfLplA1 function, western blots were performed. The results show
that parasites co-transfected with knockout and expression plasmid
express two proteins that are recognised by the P. falciparum LplA1
antiserum. The two proteins are 70.3% identical (Fig. 3) suggesting
that it is likely that the antibody raised against the P. falciparum
LplA1 protein cross-reacted with the P. berghei protein. This was
corroborated by performing a western blot performed on P. berghei
blood stage parasite lysate (Fig. 5D). Consistent with this, the blot
of the double transfectants revealed the presence of two protein
bands of about 45 kDa mass that were barely separated from each
other while the antibody only recognised a single protein of similar
size in the wild-type parasites (Fig. 4E). A similar result was
obtained when a P. falciparum line that was only transfected with
pHrBI-PbLplA1 was analysed by western blotting, which also
revealed that the antiserum raised against PfLplA1 detected two
proteins of the expected sizes in these independent transfectants
(Fig. 5C). That both proteins appear to migrate faster in the SDS-
PAGE than their predicted sizes is likely to be due to the fact that
the mitochondrial targeting peptide has been cleaved and the
observed sizes correspond to those of the mature proteins. From
these experiments we concluded that it is not easily possible to
target the P. falciparum LplA1 gene locus and we tentatively suggest
that LplA1 has an important, if not essential function for P.
falciparum during their erythrocytic development.
Knockout studies of LplA1 in P. berghei
To further investigate the role of LplA1, knockout of the LplA1
gene was attempted in the murine malaria parasite P. berghei. Two
knockout strategies were employed - the first one using single
cross-over recombination, similar to the strategy described above
for P. falciparum, and the second using double cross-over
recombination techniques [21].
The first strategy should result in a disruption of the endogenous
gene locus and generate two incomplete copies of PbLplA1 - one
truncated at the 39end and one truncated at the 59end (Fig. 6A).
This strategy was also used to generate a knock-in construct which
should lead to a reconstitution of the endogenous gene upon
integration of the plasmid into the PbLplA1 gene locus. Parasites
were transfected three times with linearised KO-plasmid and after
pyrimethamine selection in mice the resistant parasites were
subjected to diagnostic PCR analyses (Fig. 6B). According to the
PCR results, only endogenous PbLplA1 and plasmid were
amplified (lanes 3 and 4 in Fig. 6B), but no PCR product was
obtained with the diagnostic primer sets for a disruption of the
PbLplA1 gene locus (lanes 1 and 2 in Fig. 6B). These data suggest,
similar to those described above for P. falciparum, that the LplA1
locus in P. berghei might either be refractory to recombination or
that LplA1 knockout cannot be achieved because of the essential
function of the gene/protein. The first conclusion can be excluded
because transfection of P. berghei with the control plasmid b3D-
LplA-int2 resulted in pyrimethamine resistant parasites that
showed integration of the plasmid into the PbLplA1 gene locus
Figure 1. The P. falciparum LplA1 locus cannot be disrupted. A. Schematic representation of endogenous PfLplA1 gene locus (I.), transfection
plasmid pHH1-LplA-KO (II.) and PfLplA1 gene locus after single cross-over recombination (III.). The restriction enzyme used for diagnostic digest is
shown (NdeI) and the expected sizes of diagnostic bands after hybridization with PfLplA1 or hDHFR (human dihydrofolate reductase) probes are
indicated. B. Southern blot analyses of P. falciparum transfected with pHH1-LplA1-KO. Genomic DNA of wild-type D10 (lane 1) and PfLplA1-KO after 3
selection cycles with WR99210 (lane 2) was digested with NdeI and the Southern blot was probed with the P. falciparum LplA1 ORF. The 1.9 kb band
that corresponds to endogenous PfLplA1 is visible in both lanes, whereas the transfection plasmid pHH1-LplA1-KO (6 kb band) only is recognised by
the probe in the transfectants. No other bands are visible that are diagnostic for the integration of the PfLplA1 gene locus.
doi:10.1371/journal.pone.0005510.g001
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(Fig. 7). The authenticity of the PCR products was verified by
sequence analysis confirming that the LplA1 locus in P. berghei is not
refractory to recombination.
The second approach in the P. berghei system was to replace the
endogenous PbLplA1 gene with the selectable marker T. gondii
DHFR-TS using the transfection plasmid b3D-LplA-REP. Linear-
ised DNA was transfected at 6 independent occasions and
pyrimethamine resistant parasites were analysed by PCR (Fig. 8).
The results showed that re-circularisation of the linearised plasmid
had occurred in 5 out of the 6 occasions, which usually leads to loss
of linearised DNA because the drug pressure applied selects for the
presence of the circular plasmid containing the selectable marker.
In those parasites, the gene locus was still intact as expected.
However, in parasite line 6, it was possible to amplify the
diagnostic product for the PbLplA1 gene replacement after two
rounds of PCR (Fig. 8B). Again this was verified by subcloning the
PCR fragment and analysing its nucleotide sequence. However,
this mutant parasite line was lost after transfer into a new animal -
a procedure that is routinely performed to propagate the knockout
parasite population and to be able to generate clones (Fig. 8C).
Figure 2. Genotypic analysis of P. falciparum transfected with the complementation construct pHH1-LplA1-KOkon. A. Schematic
representation of endogenous PfLplA1 gene locus (I.), transfection plasmid pHH1-LplA1-KOkon (II.) and PfLplA1 gene locus after single cross-over
recombination (III.). The restriction enzyme used for diagnostic digest is shown (NdeI) and the expected sizes of diagnostic bands after hybridization
with PfLplA1 or hDHFR are indicated. B. Southern blot analyses of transfected parasite lines. Genomic DNA of wild-type and LplA1-KOkon parasites was
digested with NdeI and probed with the PfLplA1 ORF (left panel). In all parasite lines analysed, the endogenous gene is present (1.9 kb band) and in
lanes 3 and 4 two additional DNA fragments are detected by the probe (in lane 2 less DNA was loaded on the gel so that the plasmid band is hardly
visible). The faint 6 kb band is diagnostic for the presence of the transfection plasmid (see scheme), but the band of ,9 kb (*) cannot be assigned to
any specific integration event. Lane 1, wild-type D10; lane 2, PfLplA-KOkon, cycle 1; lane 3, PfLplA-KOkon, cycle 2; lane 4, PfLplA-KOkon, cycle 3. The
same blot was stripped and re-probed with the probe specifically detecting the selectable marker hDHFR and apart from faint plasmid bands at 6 kb
in lanes 2, 3 and 4 two additional bands of ,9 kb (*) and 0.5 kb (*) are detected. Lane 1, wild-type D10; lane 2, PfLplA-KOkon, cycle 1; lane 3, PfLplA-
KOkon, cycle 2; lane 4, PfLplA-KOkon, cycle 3. C. Genotyping by pulsed field gel electrophoreses. Chromosomes of wild-type P. falciparum D10 (lane 1)
and parasites transfected with the pHH1-LplA1-KOkon construct in cycle 0 (lane 2) and cycle 3 (lane 3) were analysed by PFGE and the blots were
probed with the PfLplA1 open reading frame (left panel) or with the hDHFR open reading frame (right panel) present in the transfection plasmid. The
PfLplA1 probe detected the endogenous PfLplA1 gene locus on chromosome 13 in wild-type and transfected parasites. However, the probe also
detected a strong signal at the bottom of the blot where the non-separated chromosomes ,10 are running. The hDHFR probe similarly generated
signals on chromosome ,10, but there is no sign of integration into the LplA1 gene locus on chromosome 13.
doi:10.1371/journal.pone.0005510.g002
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These data support that the LplA1 locus can be targeted not only
by the control plasmid, but also by the replacement plasmid.
However, the results suggest that the knockout of the LplA1 gene
might have severe effects on parasite growth rate and survival
during erythrocytic development.
Discussion
The ligation of LA to apo-E2 subunits of the KADH or the apo-
H-protein of the GCS is likely to be an essential reaction in most
organisms, unless it can be replaced by the LA biosynthesis
pathway like in most bacteria [6]. In Plasmodium LA biosynthesis
and salvage are located in two different organelles, the
mitochondrion and the apicoplast [8,10–12]. It further appears
that LA cannot be exchanged between the two organelles
suggesting that knockout of the mitochondrial salvage pathway
might be lethal for the parasites [13–15]. However, Plasmodium
possesses two LplA-like proteins with LplA1 present in the
mitochondrion and LplA2 present in both mitochondrion and
apicoplast [11,12,16]. This situation raises the question whether
Figure 3. Alignment of P. falciparum LplA1 and P. berghei LplA1. The deduced amino acid sequences of PF13_0083 and PB 000283.02.0 were
aligned using ClustalW. The identity between the two sequences was determined to be 70.3% while the similarity is 78%. The predicted sizes of the
two proteins are almost identical with 47.94 kDa for PfLplA1 and 47.97 kDa for PbLplA1. Identical residues are labelled in yellow; homologous
residues are labelled in green. Consensus: gives the consensus amino acid sequence of both proteins.
doi:10.1371/journal.pone.0005510.g003
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there is redundancy between the two ligases as it was shown that
LplA2 can partially compensate for LipB function in the apicoplast
[16]. However, our data do not give conclusive information about
potential redundancy between LplA1 and LplA2 in P. falciparum,
because it was impossible to target the LplA1 gene locus, even in
the presence of an expressing episomal copy of the gene; neither
was it possible to target the P. falciparum LplA1 locus with a knock-
in construct (see Fig. 2 and 4).
Therefore, we decided to expand our efforts and attempt a
knockout of the LplA1 gene in the murine malaria parasite P.
Figure 4. Genotyping of the double transfection in P. falciparum with the targeting construct pHH1-LplA1-KO and the trans-species
expression construct pHrBI-PbLplA1. The expression plasmid was transfected into the P. falciparum line already carrying pHH1-LplA1-KO in cycle
0. A. Schematic representation of the plasmid pHrBI-PbLplA1 carrying the expression cassette of P. berghei LplA1 which is under the control of the
PfHSP86 promoter. B. Genotyping of co-transfected parasite lines. Genomic DNA of wild-type (lane 1) and co-transfected parasites isolated after
selection cycle 0 to 3 following transfection (lanes 2 to 5) was digested with NdeI, and the blot was probed with the PfLplA1 open reading frame. The
blot showed the endogenous PfLplA1 gene specific band at 1.9 kb in lane 2 (cycle 0 after transfection). The pHH1-LplA1-KO plasmid (6 kb) was visible
in cycle 0 (lane 2) and an additional DNA fragment was recognised by the probe, which is unrelated to any expected fragments. The P. falciparum
LplA1 probe did not recognise the presence of the 9 kb pHrBI-PbLplA1 expression plasmid (see Supplementary Figure 2) but the signal on the blot is
due to recombination of pHH1-LplA1-KO into an un-related gene locus. The 6 kb pHH1-LplA1-KO plasmid band disappears in lanes 3 to 5 while the
,9 kb band is prominent in these parasite lines. C. Using a hDHFR probe it was established that the 9 kb band contains both P. falciparum LplA1 and
the selectable marker suggesting that the plasmid had targeted a gene locus unrelated to PfLplA1. D. Analyses of the co-transfected parasite lines by
PFGE supports that the pHH1-LplA1-KO plasmid had recombined with an unrelated gene locus (probe hDHFR, right panel). Reprobing the blot with
the BSD probe (middle panel) that specifically recognises the pHrBI-PbLplA1 expression construct, showed that the expression plasmid was also
present on a chromosome that was not resovled under the conditions of this PFGE. The PfLplA1 locus was recognised by the PfLplA1-specific probe
(left panel). Lanes 1, wild-type; lanes 2, P. falciparum co-transfected with LplA1-KO and pHrBI-PbLplA1, cycle 0; lanes 3, P. falciparum co-transfected
with LplA1-KO and pHrBI-PbLplA1, cycle 3. E. Expression of LplA1 protein in co-transfected parasites. The western blot shows parasite extracts that
were isolated from wild-type (lane 1) and two independent P. falciparum lines co-transfected with pHH1-LplA1-KO and pHrBI-PbLplA1 (lanes 2 and 3)
probed with a rabbit anti-P. falciparum LplA1 antibody at 1:1000 dilution. The antibody detects one band in the wild-type parasite extracts that
corresponds to the endogenous LplA1 protein. In the co-transfected parasite lines an additional protein is detected, which presumably corresponds
to the P. berghei LplA1 protein expressed from pHrBI-PbLplA1. The blot was re-probed with a rabbit antibody raised against P. falciparum 1-Cys
peroxiredoxin as a loading control.
doi:10.1371/journal.pone.0005510.g004
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berghei. The P. berghei LplA1 gene locus is targetable by knock-in and
also a gene replacement construct, clearly demonstrating that this
gene locus is not refractory to recombination in P. berghei. Given
that the genetic organisation of the LplA1 gene locus is highly
syntenic in P. falciparum and P. berghei, it is possible that the failure
to obtain a gene disruption of LplA1 in P. falciparum is due to its
important function for the parasites during their erythrocytic
development. This was also suggested by Allary and colleagues
[13] who showed that inhibition of P. falciparum LplA1 by the LA
analogue 8-bromooctanoic acid had deleterious effects on parasite
survival. Thus, it appears that LplA1 function cannot be replaced
by LplA2 despite the dual targeting of this protein into apicoplast
and mitochondrion. One reason for this lack of redundancy might
be the different expression profiles of LplA1 and LplA2 genes in P.
falciparum; PfLplA1 mRNA is primarily present throughout the
intraerythrocytic life of the parasites while PfLplA2 seems to be
primarily expressed in the sexual stages of the parasites [22].
Another possible explanation for the lack of redundancy between
the two proteins might be their differential substrate specificities as
has previously been suggested by Allary et al. [13]. This is not
unusual and has been described before in Listeria monocytogenes,
where the two LplAs present in the LA auxotroph organism act on
distinct substrates [23,24]. Thus, substrate specificity and time of
expression might regulate the function of LplA1 and LplA2 in P.
falciparum. Our preliminary data on the effect of a LplA2 knockout
in P. berghei suggest, however, that the protein is not essential for
Figure 5. Analysis of P. falciparum harbouring pHrBI-PbLplA1. A. Southern blot of P. falciparum transfected with pHrBI-PbLplA1 before
transfection (lane 1) and after transfection (lanes 2 and 3). The DNA was digested with NdeI and the blot was probed with the PfLplA1 ORF. The DNA
fragment recognised by the probe corresponds to the endogenous PfLplA1 gene. The PfLplA1 probe did not cross-react with the transfected plasmid
pHrBI-PbLplA1. B. To verify the presence of the transfected plasmid, the blot was re-probed with a probe specifically recognising the blasticidin S
deaminase ORF present on the plasmid as selectable marker. The probe hybridised with a DNA fragment diagnostic for the transfected plasmid
(,9.0 kb). C. Western blot of P. falciparum expressing PbLplA1. Lane 1, non-transfected parasites; Lane 2, P. falciparum transfected with pHrBI-
PbLplA1. Equal loading was verified by re-probing the blot with a polyclonal antibody directed against the 1-Cys peroxiredoxin of P. falciparum. The
polyclonal antiserum raised against PfLplA1 recognised a protein of ,45 kDa in the wild-type parasites which corresponds roughly to the expected
size of PfLplA1 (predicted size 47.9 kDa). In the transfected parasite line carrying the pHrBI-PbLplA1 plasmid two proteins of very similar size were
detected by the antibody – presumably one corresponds to the endogenous PfLplA1 while the second band corresponds to P. berghei LplA1. This is
surprising as the predicted sizes of both proteins are virtually identical. However, it is possible that the cleavage sites of the mitochondrial targeting
peptides are distinct generating proteins that are just distinguishable by SDS-PAGE. D. Western blot of P. berghei lysate (lane 1: 16106 parasites and
lane 2: 0.26107 parasites) using P. falciparum rabbit anti-LplA1 polyclonal antibody. A band of ,45 kDa (similar size to the protein identified in the
double transfected parasites as well as the wild-type parasites only transfected with pHrBI-PbLplA1) reacts strongly with the heterologous antiserum.
doi:10.1371/journal.pone.0005510.g005
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blood stage development and has a function important for the
parasites’ development in the insect host, which is consistent with
the expression profile of this gene (Gu¨nther, Matuschweski and
Mu¨ller, unpublished data).
The P. berghei LplA1 gene locus was not only targeted by a
knock-in construct but also by the gene replacement construct,
which exchanges the PbLplA1 gene with the selectable marker
and consequently deletes the PbLplA1 gene. However, it was
impossible to characterise the PbLplA1(2) mutants because the
initial population of P. berghei LplA1 null-mutants that was
obtained appeared to be out-competed by wild-type parasites
carrying an episomal selectable marker. This suggested that the
development/growth of LplA1 null-mutants was severely com-
promised implying an important role for P. berghei during blood
stage development.
In conclusion our data suggest that the LplA1 gene in P.
falciparum is refractory to recombination, which excludes conclu-
sive information as to whether the gene is essential for the survival
of the asexual stages of this human pathogenic Plasmodium species
in vitro. Two complementary strategies to select LplA1 loss-of-
function mutant parasites of P. berghei were employed. Consistent
with a severe defect in a null-mutant we could not obtain viable
LplA1(2) parasite clones, indicating that LplA1 has a crucial
function in Plasmodium during their intraerythrocytic life and that
Figure 6. PbLplA1 is essential for propagation of asexual stages. A. Insertion strategy to generate LplA1 null mutants. The PbLplA1 genomic
locus (I.) is targeted with a HpaI-linearized targeting vector (b3D-LplA1-int1, II.) containing 59 and 39 truncations of the LplA1 open reading frame and
the T. gondii DHFR/TS positive selectable marker. Upon a single cross-over event, the region of homology is duplicated, resulting in two truncated,
non-expressed LplA1 copies in the recombinant locus (III.). Wild-type, plasmid, and integration-specific primer combinations are indicated by arrows
and sizes of expected fragments are shown. B. Genotyping indicates absence of successful integration. While episomal plasmid (primer pair b3D-1
and b3D-2 amplifying a 1.63 kb pair; lane 3) and the endogenous LplA1 gene (primer pair Pb-10 and Pb-11 amplifying a 2.48 kb fragment; lane 4) are
amplified, no integration-specific bands (lane 1 and 2: 39- and 59-specific integrations, respectively) using the primer pairs b3D-1 and Pb-11 to amplify
a 2.38 kb 39-fragment and Pb-10 and b3D-2 to amplify a 2.45 kb 59-fragment were obtained from each of 3 transfected parasite populations.
doi:10.1371/journal.pone.0005510.g006
Figure 7. PbLplA1 is susceptible to gene targeting. A. Control integration strategy to recover one functional LplA1 gene copy. The targeting
vector (b3D-LplA1-int2, II.) contains the endogenous stop codon and 39 untranslated regions of the endogenous PbLplA1 but lacks the promoter and
the start codon. Upon a single cross-over event, one functional LplA1 copy that is driven by the endogenous promoter and a 59 truncated copy of the
gene are generated (III.). Wild-type, plasmid, and integration-specific primer combinations are indicated by arrows and sizes of expected fragments
are shown. B. Genotyping indicates successful integration of the control targeting construct. Both integration-specific PCRs (lane 1, 39 specific
integration using primer pair b3D-1 and Pb-11 and lane 2, 59 specific integration using primer pair Pb-10 and b3D-2) amplified fragments of the
expected sizes and their authenticity was verified by nucleotide sequencing. The population still contains episomal plasmid (lane 3; primer pair b3D-1
and b3D-2 amplifying a 2.35 kb band which was subcloned and sequenced) and residual wild-type parasites (lane 4; primer pair Pb-10 and Pb11
fragment was amplified and subcloned and sequenced).
doi:10.1371/journal.pone.0005510.g007
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development of LplA1 inhibitors has potential for future drug
discovery.
Materials and Methods
Materials
Plasmids pHH1, pHBG and pHrBI-1/2 were kind gifts of
Professor A.F. Cowman (The Walter and Eliza Hall Institute,
Melbourne, Australia) and Professor G.I. McFadden (University of
Melbourne, Melbourne, Australia), respectively. Plasmid
b3D.DT‘H.‘D was a kind gift of Professor A. P. Waters (Leiden
University, The Netherlands) [25]. P. berghei was grown in NMRI
(Naval Medical Research Institute) outbred mice (Charles River
Laboratory, Sulzfeld, Germany), or Sprague-Dawley outbred rats
(Charles River Laboratory, Sulzfeld, Germany).
Parasites
P. falciparum D10 (Papua New Guinea) were cultured according
to [26] in complete RPMI 1640 medium containing 0.1%
Albumax II (Invitrogen) at 5% haematocrit. The cultures were
maintained at 37uC in an atmosphere of reduced oxygen (3%
CO2, 1% O2, 96% N2). Before transfection with pHH1-LplA1-
KO, pHH1-LplA1-KOkon or pHrBI-PbLplA1, parasites were
synchronised using sorbitol according to [27]. Genomic DNA of
parasites was isolated using the QIAamp DNA Mini Kit (Qiagen)
after parasites were isolated from the red blood cells through
saponin lysis [28]. Chromosome blocks for pulse field gel
electrophoresis were generated according to standard procedures.
Briefly, a 10 ml culture with approximately 5% parasitemia was
saponin-lysed and the parasites were pelleted by centrifugation.
The parasite pellet was resuspended in 3 pellet volumes of warm
(,50uC) phosphate buffered saline (PBS) and the same volume of
2% (w/v) warm low melting point agarose (Invitrogen) was added
and the mixture, transferred to plug-molds (BioRad) and allowed
to set. Subsequently, the blocks were transferred into 10 mM Tris/
HCl buffer pH 8.0 containing 0.5 mM EDTA, 1% (v/v) sarkosyl
and fresh proteinase K at 2 mg/ml and incubated for 48 h at
37uC to free the nucleic acids. Chromosome blocks were stored for
up to 7 months in 10 mM Tris/HCl buffer pH 8.0 containing
50 mM EDTA at 4uC.
Protein extracts were prepared from saponin-isolated parasites
by resuspending the pellets in lysis buffer (100 mM HEPES
(pH 7.4), 5 mM MgCl2, 10 mM EDTA, 0.5% (v/v) TritonX-100,
5 mg/ml RNAse, 1 mM phenylmethylsulphonyl fluoride, 1 mM
benzamidine, 2 mg/ml leupeptin, 10 mM E-64, 2 mM 1,10-
phenanthroline, 4 mM pepstatin A) followed by three cycles of
Figure 8. PbLplA1 is sublethal for asexual parasite growth. A. Gene replacement strategy to generate potential LplA1-REP null mutants. The
wild-type PbLplA1 genomic locus (I.) is targeted with a KpnI/SacII-linearized replacement vector (b3D-LplA1-REP; II.) containing 59 and 39 regions of
the LplA1 open reading frame that flank the T. gondii DHFR/TS positive selectable marker. Upon a double cross-over event, the endogenous LplA1
gene is replaced by the selection marker (III.). Wild-type, plasmid, and replacement-specific primer combinations are indicated by arrows and
expected sizes of diagnostic PCRs are given. B. Genotyping indicates transient replacement parasites (left panel). Lane 1: PCR of 39-replacement
fragment using primer pair b3D-1 and Pb-11 which amplified a PCR fragment of 1.18 kb. The fragment was subcloned and its nucleotide sequence
verified. Lane 2: PCR using b3D-1 and b3D-2 to amplify a 1.15 kb fragment diagnostic for the recombined episome. Lane 3: PCR diagnostic for
presence of wild-type parasites using primer combination Pb-3 and Pb-12 amplifying a 1.84 kb fragment which was sequenced to verify its
authenticity. C. Diagnostic PCRs after the mixed population was transferred into a fresh animal. Lane 1: PCR with primer pair Pb-10 and b3D-3 to
amplify the 59-integration fragment of 1.02 kb. No clear product was detectable. Lane 2: PCR with primer pair b3D-1 and Pb-11 to amplify the 39-
integration fragment of 1.18 kb. No product was detectable. Lane 3: PCR of episomal recombined plasmid using b3D-1 and b3D-2 to amplify a
1.15 kb band. The fragment was subcloned and its sequence verified. Lane 4: PCR diagnostic for presence of wild-type parasites using primer
combination Pb-10 and Pb-11 amplifying a 2.47 kb fragment which was sequenced to verify its authenticity.
doi:10.1371/journal.pone.0005510.g008
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freeze/thawing and sonication in a sonicating water-bath (Fish-
erbrand). Protein concentrations were determined using the
Bradford assay [29].
Asynchronous blood-stages of P. berghei (strain NK65) were
maintained in NMRI mice. For isolation of synchronized late stage
schizonts 5 ml infected blood was obtained by cardiac puncture
from a Sprague/Dawley rat and cultured overnight in RPMI
1640, supplemented with 20% (v/v) fetal calf serum, 25 mM
HEPES, 25 mM glutamine, and 14 mg/ml gentamycin. Parasites
were isolated by gradient centrifugation and used for subsequent
transfection with the constructs b3D-LplA1-int1 and int2 and b3D-
LplA1-REP. Genomic DNA of P. berghei parasites was isolated from
blood obtained from an infected animal by cardiac puncture and
erythrocytes, lymphocytes and platelets were separated using a
cellulose column. The red blood cells were then lysed in 0.2% (w/
v) saponin in PBS and after washing the resulting parasite pellet in
PBS, it was resuspended in 200 ml of PBS and stored at 220uC
before genomic DNA was extracted using the QIAamp DNAMini
Kit (Qiagen).
Transfection of parasites
The constructs pHH1-LplA1-KO and pHH1-LplA1-KOkon
were generated using the oligonucleotides Pf-1/Pf-2 and Pf-3/Pf-
4, respectively (see Table 1). The primers introduced 59 of the
PCR products a BglII site and 39 a XhoI site that allowed
directional cloning of the products into pHH1 [30]. PCR was
performed with Pfu polymerase and genomic P. falciparum DNA.
The knockout construct is truncated at its 59 end lacking the ATG
start codon and at the 39 end, a premature stop codon was
introduced 237 bp upstream of the natural stop codon. This would
result in the formation of two incomplete and inactive LplA1 copies
upon single cross-over recombination of the plasmid in the LplA1
gene locus. In contrast, the control construct, corresponding to
nucleotides 206–1227, retains the endogenous C-terminus of the
LplA1 gene but lack the 59 end and thus should generate a
functional copy of LplA1 and a non-functional pseudogene upon
recombination. It will, however, introduce an artificial 39 UTR
downstream of the first LplA1 copy [30]. The expression plasmid
pHrBI-PbLplA1 encompasses the entire ORF of the P. berghei LplA1
gene, which was amplified from P. berghei genomic DNA using the
oligonucleotides Pb-1 and Pb-2 (see Table 1). The introduced
restriction sites BglII and NotI allowed directional cloning of the
PCR product into the Gateway entry vector pHGB [31]. Through
recombination using the single site Gateway cloning system
(Invitrogen), the PbLplA1 ORF was transferred into the destination
vector pHrBI-1/2 which contains the blasticidin S deaminase
(BSD) as a selectable marker [31]. All PCR products were initially
subcloned into TOPO-Blunt (Invitrogen) and their sequences were
verified (The Sequencing Service, University of Dundee, UK,
www.dnaseq.co.uk) before cloning into the transfection plasmid
pHH1 or entry vector pHGB. Transfection of the constructs was
carried out as described before [32,33] and parasites were selected
with either 5 nM WR99210 or 2 mg/ml blasticidin (Invitrogen).
The expression plasmid pHrBI-PbLplA1 was transfected into P.
falciparum D10 and the P. falciparum line carrying the pHH1-LplA1-
KO plasmid (cycle 0).
The b3D.DT‘H.‘D-based knockout construct [25] for single
homologous recombination in P. berghei encompasses a 1014 bp
PbLplA1 fragment corresponding to nucleotides 88 to 1098 (lacking
the last 147 bp) which was amplified using the oligonucleotides
Pb-3 and Pb-4 (see Table 1), Pfu polymerase and genomic P. berghei
DNA. An artificial stop codon was introduced at the 39 end of the
PCR product and the fragment was cloned into the BamHI and
SacII sites of one of the multiple cloning sites of the vector resulting
in b3D-LplA1-int1. Similar to the strategy described above for P.
falciparum, transfection with this construct should result in the
disruption of the gene locus and the formation of two incomplete
and inactive copies of LplA1. The control plasmid b3D-LplA1-int2
encompasses a 1734 bp PCR fragment and was amplified using
Pb-3 and Pb-5. As the knockout construct, it was cloned into the
BamHI and SacII sites of b3D.DT‘H.‘D. This fragment is
truncated at the N-terminus of the gene (lacking the first 87 bp)
but comprises the full–length C-terminus including the endoge-
nous stop codon and 39UTR and single homologous recombina-
tion should therefore result in the reconstitution of the endogenous
gene. Both plasmids were digested with HpaI to linearise the vector
before transfection into NK65 wild-type parasites according to
[25]. The transfections were performed one to three times. In a
second strategy PbLplA1 59 UTR and 39 UTR regions were
cloned into the two multiple cloning sites of b3D.DT‘H.‘D
using the oligonucleotides Pb-6/Pb-7 and Pb-8/Pb-9, respectively
(see Table 1). The 59 UTR PCR fragment was 480 bp in length
and contained KpnI and HindIII restriction sites; the 39UTR PCR
fragment was 516 bp long and had NotI and SacII restriction sites
that allowed directional cloning. The resulting plasmid was called
b3D-LplA1-REP. Using KpnI and SacII, the transfection cassette
(containing the two LplA1 UTRs and the selectable marker T.
gondii dihydrofolate reductase-thymidylate synthase (TgDHFR-TS)
was isolated from the plasmid backbone, and digested plasmid was
transfected according to [25]. The transfection was repeated at 6
independent occasions.
Southern blot analyses
For each P. falciparum line that was analysed, 1 to 5 mg of
genomic DNA was digested with NdeI, separated on a 0.8% (w/v)
agarose gel and blotted onto positively charged nylon membrane
(GE Healthcare) using standard methods [34]. The blots were
prehybridised in 56 SSC, 0.1% (w/v) SDS, 5% (w/v) dextrane
sulphate and 1:20 dilution of GI liquid block provided with the
Gene Images CDP-Star detection kit from GE Healthcare. After
2 h at 60uC either the fluoresceine-labelled LplA coding region, the
human DHFR (hDHFR) or the blasticidin S deaminase (BSD) probes,
generated using the Gene Images Random Prime labelling module
according to the manufacturer’s recommendation (GE Health-
care), were added and the blots hybridised overnight at the same
temperature. After washes with decreasing salt-concentrations, the
signals were detected by incubating the blots with an anti-
fluoresceine alkaline phosphatase conjugated antibody followed by
several washes in 100 mM Tris HCl pH 9.5 containing 300 mM
NaCl and 0.3% (v/v) Tween 20. After application of detection
solution the blot was exposed to autoradiography film (Kodak).
Pulsed field gel electrophoreses
To separate P. falciparum chromosomes on an agarose gel, pulse
field gel electrophoreses were performed using the CHEF-DR III
Variable Angle System (BioRad). The conditions used in this study
are optimal to separate chromosomes 11 to 14 because the LplA1
gene is located on chromosome 13. The gel consisted of 1% (w/v)
agarose in 16TAE and the separation was performed using the
following parameters: 360–800 s pulse, 3 V/cm2 (100 Volts) for
96 hours. The gels were blotted and probed as described above.
Western blot analyses
To detect whether P. falciparum transfected with pHrBI-PbLplA1
alone or P. falciparum co-transfected with pHH1-LplA1-KO and
pHrBI-PbLplA1 expressed P. berghei LpA1 protein in addition to the
endogenous P. falciparum LplA1 protein, parasite extracts of wild-
type and mutant parasites were subjected to western blot analyses.
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Briefly, 15 mg of P. falciparum lysates or the protein extract obtained
from 16106 or 0.26107 P. berghei were separated on a 4–12%
SDS-PAGE (Invitrogen) and then blotted onto nitrocellulose
(Schleicher and Schu¨ll), using standard techniques [34]. The blots
were incubated with a rabbit anti-LplA1 antibody (generated
against recombinant protein P. falciparum LplA1 by Eurogentec,
Belgium) at a dilution of 1:5000 and the secondary anti-rabbit IgG
(H+L), HRP conjugate (Promega) at a dilution of 1:10,000 before
being developed using the ImmobilonTM Western Chemilumines-
cent HRP Substrate (Millipore).
PCR analyses of P. berghei transfectants
The parasite populations that were isolated from infected mice
after transfection of the three P. berghei constructs were analysed by
PCRs using diagnostic primer combinations that allowed deter-
mining whether (i) the gene locus had been targeted by the
plasmid, (ii) the endogenous gene was still present and (iii) the
plasmid had recombined and was present as an episome. The
parasites that were transfected with b3D-LplA1-int1 were analysed
with primer pair Pb-10/Pb-11 which should result in the
amplification of a 2479 bp fragment if the endogenous gene was
still present. In order to analyse whether the recombined
transfection plasmid was present in the parasite population,
primers b3D-1 and b3D-2 were used, amplifying a 1628 bp
fragment. For amplification of PCR products diagnostic for the
homologous recombination of the transfected construct with the
gene locus, the two primer sets b3D-1/Pb-11 and Pb-10/b3D-2
were used to analyse the 39 and 59 integration-specific events,
respectively. The parasites transfected with the control plasmid
b3D-LplA1-int2 were analysed with the same primer sets.
Parasites transfected with the replacement construct b3D-
LplA1-REP were analysed using the gene locus specific primer
set Pb-3/Pb-11 (amplifying a 1837 bp product) or Pb-10/Pb-12
(amplifying a 2479 bp product). These parasite lines were also
analysed for the presence of plasmid using the primer pair b3D-1
and b3D-2, amplifying a 1150 bp fragment. Diagnostic PCRs for
the integration event were performed for the 39 and 59 integration
site using the primer combinations b3D-1/Pb-11 (1183 bp) and
Pb-10/b3D-3 (1015 bp), respectively (for primer sequences see
Table 1).
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